Curcumin inhibits ultraviolet light induced human immunodeficiency virus gene expression

Molecular and Cellular Biochemistry

Volumn 254, Issue 1-2, 2003, Pages 289-297

  Taher, Mohiuddin M ^a,d   Lammering, Guido ^c   Hershey, Chad ^b   Valerie, Kristoffer ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d NONE   (United States)

Author keywords

Herbal medicine; HIV AIDS; MAP kinases; NF B; Radiation; Turmeric powder

Indexed keywords

CURCUMIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P42; PROTEIN P44; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; CAT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERMINAL REPEAT; MODULATION; NONHUMAN; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; ULTRAVIOLET RADIATION; VIRUS GENE;

BLOTTING, WESTERN; CELL NUCLEUS; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, VIRAL; HELA CELLS; HIV; HIV LONG TERMINAL REPEAT; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE C; TIME FACTORS; ULTRAVIOLET RAYS;

ANIMALIA; CURCUMA LONGA; FELIS CATUS; HUMAN IMMUNODEFICIENCY VIRUS; JANUS; RNA VIRUSES;

EID: 0344034317     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027393719610     Document Type: Review

References (54)

1. Araujo CC, Leon LL: Biological activities of Curcuma longa L. Mem Inst Oswaldo Cruz 96: 723-728, 2001
2. Lodha R, Bagga A: Traditional Indian system of medicine. Ann Acad Med Singapore 29: 37-41, 2000
3. De Clercq E: Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection. Med Res Rev 20: 323-349, 2000
4. Huang MT, Ma W, Yen P, Xie JG, Han J, Frenkel K, Grunberger D, Conney AH: Inhibitory effects of topical application of low doses of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and oxidized DNA bases in mouse epidermis. Carcinigenesis 18: 83-88, 1997
5. Xu YX, Pindolia KR, Janakiraman N, Chapman RA, Gautam SC: Curcumin inhibits IL1 and TNF-alpha induction of AP-1 and NF-κB DNA-binding activity in bone marrow stromal cells. Hematopathol Mol Hematol 11: 49-62, 1997-1998
6. Chan MM, Huang HI, Fenton MR, Fong D: In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochem Pharmacol 55: 1955-1962, 1998
7. Zhang F, Altori NK, Mestre JR, Subbaramaiah K, Dannenberg AJ: Curcumin inhibits cyclooxygenase-2 transcription in bile acid-and phorbol ester-treated human gastrointestinal epithelial cells. Carcinogenesis 20: 445-451, 1999
8. Liu JY, Lin SJ, Lin JK: Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells. Carcinogenesis 14: 857-861, 1993
9. Hasmeda M, Polya GM: Inhibition of cyclic AMP-dependent protein kinase by curcumin. Phytochemistry 42: 599-605, 1996
10. Chen YR, Tan TH: Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene 17: 173-178, 1998
11. Korutla L, Kumar R: Inhibitory effects of curcumin on epidermal growth factor receptor kinase activity in A431 cells. Biochim Biophys Acta 1224: 597-600, 1994
12. Seger R, Krebs EG: The MAPK signaling cascade. FASEB J 9: 726-735, 1995
13. Davis RJ: The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268: 14553-14556, 1993
14. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, Davis RJ: Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270: 7420-7426, 1995
15. Ip YT, Davis RJ: Signal transduction by the c-jun-N-terminal kinase (JNK)-from inflammation to development. Curr Opin Cell Biol 10: 205-219, 1998
16. Hill CS, Treisman R: Transcriptional regulation by extra cellular signals: Mechanisms and specificity. Cell 80: 199-211, 1995
17. Kyriakis JM, Avruch J: Protein kinase cascades activated by stress and inflammatory cytokines. Bioassays 18: 567-577, 1996
18. Baldassare JJ, Bi Y, Bellone CJ: The role of p38MAPK in IL-1β transcription. J Immunol 162: 5367-5373, 1999
19. 2-induced cell death. J Biol Chem 275: 16590-16596, 2000
20. Chen P, Flory E, Avots A, Jordan BWM, Kirchhoff F, Ludwig S, Rapp UR: Transactivation of naturally occurring HIV-1 long terminal repeats by the JNK signaling pathway: The most frequent naturally occurring length polymorphism sequence introduces a novel binding site for AP-1 factors. J Biol Chem 27: 20382-20390, 2000
21. Taher MM, Baumgardner T, Dent P, Valerie KC: Genetic evidence that stress-activated p38 MAP kinase is necessary but not sufficient for UV activation of HIV gene expression. Biochemistry 38: 13055-13062, 1999
22. Taher MM, Oakley JD, Hershey CM, Valerie KC: Activation of NF-κB and p38 MAP kinase is not sufficient for triggering efficient HIV gene expression in response to stress. Biochemistry 39: 1709-1715, 2000
23. Taher MM, Hershey CM, Oakley JD, Valerie KC: Role of the p38 and MEK-1 and2/p44/42 MAP kinase pathways in the differential activation of human immunodeficiency virus gene expression by ultraviolet and ionizing radiation. Photochem Photobiol 71: 455-459, 2000
24. Schmidt-Ullrich RK, Dent P, Grant S, Mikkelsen RB, Valerie K: Signal transduction and cellular radiation responses. Radiat Res 153: 245-257, 2000
25. 2-terminal kinase dependent, p53 independent pathway. Cancer Res 59: 3053-3058, 1999
26. van Dam H, Wilhelm D, Herr I, Steffen A, Herrlich P, Angel P: ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J 14: 1798-1811, 1995
27. Dhanwada KR, Dickens M, Neades R, Davis RJ, Pelling JC: Differential effects of UV-B and UV-C components of solar radiation on MAP kinase signal transduction pathways in epidermal keratinocytes. Oncogene 11: 1947-1953, 1995
28. Duh EJ, Maury WJ, Folks TM, Fauci AS, Rabson AB: Tumor necrosis factor α activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-κB sites in the long terminal repeat. Proc Natl Acad Sci USA 86: 5974-5978, 1989
29. Nabel G, Baltimore D: An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (London) 326: 711-713, 1987
30. Dinter H, Chiu R, Imagawa M, Karin M, Jones KA: In vitro activation of the HIV-1 enhancer in extracts from cells treated with a phorbol ester tumor promoter. EMBO J 6: 4067-4071, 1987
31. Maio JJ, Brown FL: Regulation of expression driven by human immunodeficiency virus type I and human T-cell leukemia virus type I long terminal repeats in pluripotential human embryonic cells. J Virol 62: 1398-1407, 1988
32. Tong-Starksen SE, Luciw PA, Peterlin BM: Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat. J Immunol 142: 702-707, 1989
33. Kumar S, Orsini MJ, Lee JC, McDonnell PC, Debouck C, Young PR: The activation of the HIV-1 Long terminal repeat induced by cytokines and environmental stress requires an active p38 MAP kinase. J Biol Chem 271: 30864-30869, 1996
34. Cohen PS, Schmidtmayerova H, Dennis J, Dubrovsky L, Sherry B, Wang H, Bukrinsky M, Tracey KJ: The critical role of p38 MAP kinase in T cell HIV-1 replication. Mol Med 3: 339-346, 1997
35. Taher MM, Lammering G, Hershey CM, Valerie KC: Mood enhancing antidepressant St. John's Wort inhibits the activation of human immunodeficiency virus gene expression by ultraviolet light. IUBMB Life 54: 357-364, 2003
36. Valerie K, Delers A, Bruck C, Thiriart C, Rosenberg H, Debouck C, Rosenberg M: Activation of human immunodeficiency virus type 1 by DNA damage in human cells. Nature (London) 333: 78-81, 1988
37. Valerie K Laster WS Kirkham JC Kuemmerle NB: Ionizing radiation activates nuclear factor κB but fails to produce an increase in human immunodeficiency virus gene expression in stably transfected human cells. Biochemistry 34: 15768-15776, 1995.
38. Shapiro L, Heidenreich KA, Meintzer MK, Dinarello CA: Role of p38 mitogen-activated protein kinase in HIV type-1 production in vitro. Proc Natl Acad Sci USA 95: 7422-7426, 1998
39. Breithaupt TB, Vazquez A, Baez I, Eylar EH: The suppression of T cell function and NF-κB expression by serine protease inhibitors is blocked by N-acetylcysteine. Cell Immunol 173: 124-130, 1996
40. Butera ST: Therapeutic targeting of human immunodeficiency virus type-1 latency: Current clinical realities and future scientific possibilities. Antiviral Res 48: 143-176, 2000
41. Gaynor R: Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS 6: 347-363, 1992
42. Dasgupta P, Saikumar P, Reddy CD, Reddy EP: Myb protein binds to human immunodeficiency virus 1 long terminal repeat (LTR) sequences and transactivates LTR-mediated transcription. Proc Natl Acad Sci USA 87: 8090-8094, 1990
43. Klaver B, Berkhout B: Comparison of 5′ and 3′ long terminal repeat promoter function in human immunodeficiency virus. J Virol 68: 3830-3840, 1994
44. Perkins ND, Edwards NL, Duckett CS, Agranoff AB, Schmidt RM, Nabel GI: A cooperative interaction between NF-κB and Sp1 is required for HIV-1 enhancer activation. EMBO J 12: 3551-3558, 1994
45. Griffin GE, Leung D, Folks TM, Kunkel S, Nabel GJ: Activation of HIV gene expression during monocyte differentiation by induction of NF-κB. Nature (London) 339: 70-73, 1989
46. Barbeau B, Bernier R, Dumais N, Briand G, Olivier M, Faure R, Posner BI, Tremblay M: Activation of HIV-1 long terminal repeat transactivation and virus replication via NF-κB-dependent and -independent pathways by potent phosphotyrosine phosphatase inhibitors, the peroxovanadium compounds. J Biol Chem 272: 12969-12977, 1997
47. Khar A, Ali AM, Pardhasaradhi BV, Begum Z, Anjum R: Antitumor activity of curcumin is mediated through the induction of apoptosis in AK-5 tumor cells. FEBS Lett 445: 165-168: 1999
48. Woloschak GE, Schreck S, Panozo J, Chang-Liu CM, Libertin CR: HIV expression is induced in dying cells. Biochem Biophys Acta 1351: 105-110, 1997
49. Oakley JD, Taher MM, Hershey C, Aggarwal PC, Estwani IB, Valerie K: Triggering of apoptosis is not sufficient to increase HIV gene expression: Separation of apoptosis and gene expression in response to UV. IUBMB, 2003 (in press)
50. Doppler C, Schalasta G, Amtmann E, Sauer G: Binding of NF-κB to the HIV-1 LTR is not sufficient to induce HIV-1 LTR activity. AIDS Res Hum Retroviruses 8: 245-252, 1992
51. Yang X, Chen Y, Gabuzda D: ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-κB. J Biol Chem 274: 27981-27988, 1999
52. Li CJ, Zhang LJ, Dezube BJ, Crumpacker CS, Pardee AB: Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication. Proc Natl Acad Sci USA 90: 1839-1842, 1993
53. Barthelemy S, Vergnes L, Moynier M, Guyot D, Labidalle S, Bahraoui E: Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat. Res Virol 149: 43-52, 1998
54. Bremner P Heinrich M: Natural products as targeted modulators of the nuclear factor-kappaB pathway. J Pharm Pharmacol 54: 453-472, 2002